Pharmascience Inc. contributes to the Montreal Heart Institute's COLchicine Cardiovascular Outcome T
MONTREAL, Nov. 16, 2019 /CNW/ - The Montreal Heart Institute (MHI) announced earlier today the results of its COLchicine Cardiovascular Outcomes Trial (COLCOT). ... Lees verder